U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07245667) titled 'Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study' on Nov. 17.
Brief Summary: This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).
Study Start Date: Dec. 30, 2024
Study Type: INTERVENTIONAL
Condition:
Tinea Pedis
Intervention:
DRUG: 1% Tolnaftate Stick Formula A
Topical antifungal stick containing 1% tolnaftate in the Formula A base. Applied twice daily for 4 weeks.
DRUG: 1% Tolnaftate Stick Formula B
Topical antifungal stick containing 1% tolnaftate in t...